Business
Why is the Medlab (ASX:MDC) share price surging 8% today?
The Medlab Clinical Ltd (ASX: MDC) share price is rising today after the European Patent Office announced its intention to grant the Australian company a patent for its Nanocelle technology.
The Medlab share price is up 8.33% today to 26 cents per share.
Medlab is a medical research and development company that’s gained a lot of publicity for its innovative medical use of THC, one of the psychoactive compounds in cannabis.
It largely focuses on THC and other cannabinoid products as pain-relievers, but the company is also engaged in researching and formulating novel biotherapeutics or new therapeutic medicines derived from natural organisms.
Its products aim to improve health outcomes in early to moderate stage chronic diseases…
-
General22 hours agoWallabies vs Italy rugby union Test live updates — blog, scores and stats from Udine
-
General20 hours agoHow the dismissal of Gough Whitlam’s Labor government in 1975 was sealed by the Senate
-
Noosa News13 hours agoPhotographer Nadia Shevtsova remembered by family in touching tribute after deadly crash at Gold Coast
-
General20 hours agoA hot mess. The ‘irregulation’ of sneaky Sportsbet